Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Hasty Decisions, Runaway Projects
Despite the best intentions of ISO and EMA, the pharma industry is still largely failing to exploit its data in a strategic, joined-up way - and this could now restrict companies’ ability to capitalize on AI. read more
An Interview With Brian Morrissey
In this interview we spoke to Brian Morrissey, General Manager of Gaelic Laboratories, about the strategy behind their acquisition of Athlone Laboratories, and its impact. read more
How Real-Time Data Analytics Can Address Common Pain Points in Clinical Trials
Major issues in clinical oversight are latency and heterogeneity across systems including formats, identifiers, coding conventions, and timing of updates. read more
The Operational Foundations That Characterize Regulatory Leaders
Holding individuals and teams explicitly accountable for data accuracy and quality might seem straightforward, but it is difficult to sustain in practice. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Kindeva Appoints Chief Transformation Officer
Monday, July 13, 2026
Kindeva announced the appointment of Brok Weichbrodt as Chief Transformation Officer to strengthen operational excellence, scale execution, and ... read more
Axplora Manufacturing Sites Earn EcoVadis Ratings Across European Network
Thursday, July 09, 2026
Axplora reported updated EcoVadis sustainability ratings for four of its European manufacturing sites, with one site achieving platinum status and ... read more
Porton Advanced's UC-MSCs Cell Bank for Exosome Manufacturing Receives FDA Drug Master File (DMF) Acceptance
Thursday, July 09, 2026
Porton Advanced announced that its Umbilical Cord-Derived Mesenchymal Stem Cell (UC-MSCs) Cell Bank for exosome manufacturing has been accepted for ... read more
WuXi Biologics’ MFG8 Facility Gains FDA Pre License Inspection Approval For Autoimmune Therapy
Thursday, July 09, 2026
WuXi Biologics has received FDA pre license inspection (PLI) approval for its MFG8 drug substance manufacturing facility in Hebei, clearing the way ... read more
Evonik Invests $100M to Upgrade Drug Substance Manufacturing Site in Lafayette, IN
Wednesday, July 08, 2026
Evonik announced it is making a significant investment to strengthen manufacturing capabilities at its Tippecanoe Labs site in Lafayette, Indiana. read more